clincal studies have shown that tobramycin sulfate is well tolerated and effective in the treatment of the infections listed below when they are caused by susceptible gram-negative organisms and by staphylococci : infections of the respiratory tract ( including cystic fibrosis ) , central nervous system , skin , soft tissue , and bone ( including burns ) ;
C0027519
tobramycin sulfate
C0035243
infections